Vav1 regulates MHCII expression in murine resting and activated B cells

Area of Science:

• Immunology
• Cell Biology
• Molecular Biology

Background:

• Vav1, a guanine nucleotide exchange factor (GEF), is primarily found in hematopoietic cells.
• While its GEF activity is known, Vav1's role in antigen-presenting cells (APCs) and its non-GEF functions are less understood.
• Vav1's structure suggests potential roles beyond GEF activity, including transcriptional regulation and protein transport.

Purpose of the Study:

• To investigate the role of Vav1 in antigen-presenting cells, specifically its regulation of MHCII expression and transport.
• To determine if Vav1's GEF activity is essential for MHCII upregulation in B cells.
• To elucidate Vav1's impact on T-cell activation.

Main Methods:

• Microarray analysis of Vav1-deficient bone marrow-derived macrophages.
• Flow cytometry to assess surface MHCII expression on immune cells from Vav1-deficient mice.
• Inhibition of Vav1's GEF activity using 6-thio-GTP in LPS-stimulated B cells.
• Assessment of T-cell activation capacity.

Main Results:

• Vav1 deficiency leads to significantly lower constitutive surface MHCII expression, particularly in splenic and peritoneal B cells.
• Vav1 plays a role in the transcriptional regulation of the MHCII locus.
• Vav1's GEF activity is required for LPS-induced MHCII upregulation in B cells.
• Vav1 influences both MHCII transcription and cell surface transport.
• Impaired MHCII expression in Vav1-deficient cells reduces T-cell activation.

Conclusions:

• Vav1 is a critical regulator of MHCII expression and transport in antigen-presenting cells.
• Both GEF-dependent and potentially GEF-independent functions of Vav1 contribute to MHCII regulation.
• Vav1 deficiency impairs immune cell function by reducing MHCII presentation, thereby affecting T-cell activation.